This exclusive annual scorecard checks bank results in a difficult year, and looks ahead at the hurdles and opportunities for the sector that many Australians rely on for their income.
Author Archive | Hugh Dive
Our regular check on the ‘star’ performances from the Australian banks’ May 2018 reporting season in the face of low credit growth, increased regulatory scrutiny and the sales of insurance and wealth management divisions.
The rapid price fall of Blue Sky following a poor report from a foreign seller makes it look as if short selling is easy, but there are many risks and details to consider along the way.
A look at the ‘star’ performances from the Australian banks’ financial results for 2017 and how they have handled non-bank competition, government levies and business divestments.
Institutional investors have little interest in investing in residential property due to the low yields and favourable taxation concessions offered to owner occupiers and retail investors.
The Grenfell Tower disaster highlighted dangers posed by faulty building materials. It’s usually property owners that bear the majority of the costs for correcting ill-considered policy or builders’ mistakes.
There’s more to a company’s profitability than the headline dollar figure. Measures such as return on equity, return on assets and profit margin can provide a much better and balanced perspective.
An insider’s view of how institutional investors approach a hot IPO and the charade that goes on between fund managers and the investment banks running the show.
The wealth management businesses of major banks may be efficient uses of their capital, but it comes with scrutiny of the vertical integration model and culture risks. There’s increasing focus on whether it’s worth having.
When analysing the latest takeover offer, these timeless country music lyrics come to mind. Because each situation is different, you’ll need to know whether to accept the offer, hold out for more, or just dump and run.
There’s been much media attention on the negative aspects of oil price falls, but some of the benefits are doing more for the economy than the government stimulus package during the GFC.
The major banks and other large companies attract a lot of attention when they report profits of billions of dollars, but other measures of profitability show the big headline figures can be misleading.
After the large falls in the prices of most resource stocks over the last year, investors might be wondering what to do. Here are a few factors to consider relating to resources at this time of great uncertainty.
Reporting season is hard work for equity analysts, especially when a company’s results differ from the expected. It’s also a time for a company to outline its strategy and gauge the reaction of its owners, the fund managers.
Investors face a barrage of glowing research from investment banks trumpeting the blue sky potential of new companies seeking to be listed on the ASX. It’s crucial to ignore the spin and focus on the business itself.
Biotech and pharma are seductive and exciting sectors to invest in. When products are developed and successfully adopted, it can be very profitable, but most projects do not succeed, and it’s good to know what you’re doing.